Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


18.12.2017

1 AJR Am J Roentgenol
1 Ann Thorac Surg
1 Anticancer Res
1 Arch Bronconeumol
1 Cancer Cell
1 Cancer Chemother Pharmacol
1 Cancer Res
2 Carcinogenesis
3 Chest
1 Clin Cancer Res
2 Clin Lung Cancer
1 Eur J Cancer
3 Eur J Cardiothorac Surg
3 Int J Cancer
1 J Clin Oncol
2 J Thorac Cardiovasc Surg
3 J Thorac Oncol
2 Lancet Oncol
1 Lancet Respir Med
1 Lung Cancer (Auckl)
1 Nat Genet
1 Oncologist
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CHUNG JH, Richards JC, Koelsch TL, MacMahon H, et al
    Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
    AJR Am J Roentgenol. 2017 Dec 12:1-11. doi: 10.2214/AJR.17.19003.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. KURIHARA N, Saito H, Usami S, Imai K, et al
    Lung Cancer Surgery in Partial Anomalous Pulmonary Venous Connection Patients.
    Ann Thorac Surg. 2018;105:e7-e9.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. MATSUBARA T, Toyokawa G, Yamada Y, Nabeshima K, et al
    A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis.
    Anticancer Res. 2017;37:6937-6941.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  4. FERNANDEZ-BUSSY S, Pires Y, Labarca G, Vial MR, et al
    PD-L1 Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA.
    Arch Bronconeumol. 2017 Dec 6. pii: S0300-2896(17)30397.
    PubMed     Text format    


    Cancer Cell

  5. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2017;32:884.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  6. KATAOKA Y, Hirano K, Narabayashi T, Hara S, et al
    Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study.
    Cancer Chemother Pharmacol. 2017 Dec 11. pii: 10.1007/s00280-017-3498.
    PubMed     Text format     Abstract available


    Cancer Res

  7. SIVAKUMAR S, Lucas FAS, McDowell TL, Lang W, et al
    Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
    Cancer Res. 2017;77:6119-6130.
    PubMed     Text format     Abstract available


    Carcinogenesis

  8. FRIXA T, Sacconi A, Cioce M, Roscilli G, et al
    MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration.
    Carcinogenesis. 2017 Dec 11. pii: 4725065. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. BU X, Kato J, Hong JA, Merino MJ, et al
    CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.
    Carcinogenesis. 2017 Dec 8. pii: 4712089. doi: 10.1093.
    PubMed     Text format     Abstract available


    Chest

  10. DHAKAL A, Chen H, Dexter EU
    A 51-Year-Old Woman With an Increasing Chest Wall Mass Years After Resection of an Early Stage Lung Cancer.
    Chest. 2017;152:e151-e154.
    PubMed     Text format     Abstract available

  11. ROEDER NL, Marshall JD, Britto CJ
    A Woman in Her 60s With Lung Adenocarcinoma Presents With Copious Watery Sputum and Respiratory Failure.
    Chest. 2017;152:e143-e146.
    PubMed     Text format     Abstract available

  12. CHIAPPETTA M, Congedo MT, Nachira D, Meacci E, et al
    Is Topographic Classification Effective for Lymph Node Metastasis in Patients Affected by Non-Small Cell Lung Cancer?
    Chest. 2017;152:1354-1355.
    PubMed     Text format    


    Clin Cancer Res

  13. YE M, Zhang Y, Gao H, Xu Y, et al
    Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small-Cell Lung Cancer by Activating Src-Mediated Bypass Signaling.
    Clin Cancer Res. 2017 Dec 11. pii: 1078-0432.CCR-17-0396.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  14. CUPP J, Culakova E, Poniewierski MS, Dale DC, et al
    Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30307.
    PubMed     Text format     Abstract available

  15. MASSABEAU C, Khalifa J, Filleron T, Modesto A, et al
    Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30314.
    PubMed     Text format     Abstract available


    Eur J Cancer

  16. ANGEVIN E, Spitaleri G, Rodon J, Dotti K, et al
    A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification.
    Eur J Cancer. 2017;87:131-139.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  17. SAJI H, Ueno T, Nakamura H, Okumura N, et al
    A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
    Eur J Cardiothorac Surg. 2017 Dec 11. pii: 4731648. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. SAGAWA M, Oizumi H, Suzuki H, Uramoto H, et al
    A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
    Eur J Cardiothorac Surg. 2017 Dec 9. pii: 4718127. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. TAKIZAWA H, Kondo K, Kawakita N, Tsuboi M, et al
    Autofluorescence for the diagnosis of visceral pleural invasion in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 8. pii: 4710341. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  20. THEOFYLAKTOPOULOU D, Midttun O, Ueland PM, Meyer K, et al
    Impaired functional vitamin B6 status is associated with increased risk of lung cancer.
    Int J Cancer. 2017 Dec 14. doi: 10.1002/ijc.31215.
    PubMed     Text format     Abstract available

  21. JIANG Z, Chen T, Chen J, Ying S, et al
    Hand-spinning chrysotile exposure and risk of malignant mesothelioma: A case-control study in Southeastern China.
    Int J Cancer. 2018;142:514-523.
    PubMed     Text format     Abstract available

  22. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    PubMed     Text format     Abstract available


    J Clin Oncol

  23. FRANCIS S, Orton A, Stoddard G, Tao R, et al
    Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Dec 13:JCO2017744771. doi: 10.1200/JCO.2017.74.4771.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  24. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Text format     Abstract available

  25. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  26. FUJIMOTO D, Sato Y, Uehara K, Ishida K, et al
    Predictive performance of four programmed cell death ligand 1 assay systems on nivolumab response in previously treated patients with non-small cell lung cancer.
    J Thorac Oncol. 2017 Dec 9. pii: S1556-0864(17)33072.
    PubMed     Text format     Abstract available

  27. STABILE LP, Farooqui M, Kanterewicz B, Abberbock S, et al
    Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.
    J Thorac Oncol. 2017 Dec 9. pii: S1556-0864(17)33076.
    PubMed     Text format     Abstract available

  28. STIEFEL F, Bourquin C
    Adverse Effects of "Teachable Moment" Interventions in Lung Cancer: Why Prudence Matters.
    J Thorac Oncol. 2017 Dec 11. pii: S1556-0864(17)32862.
    PubMed     Text format    


    Lancet Oncol

  29. BRAHMER JR, Rodriguez-Abreu D, Robinson AG, Hui R, et al
    Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Lancet Oncol. 2017;18:1600-1609.
    PubMed     Text format     Abstract available

  30. FEROLLA P, Brizzi MP, Meyer T, Mansoor W, et al
    Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
    Lancet Oncol. 2017;18:1652-1664.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  31. TZOUVELEKIS A, Spagnolo P, Bonella F, Vancheri C, et al
    Patients with IPF and lung cancer: diagnosis and management.
    Lancet Respir Med. 2017 Dec 11. pii: S2213-2600(17)30478.
    PubMed     Text format    


    Lung Cancer (Auckl)

  32. WOJCIK E, Kulpa JK
    Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
    Lung Cancer (Auckl). 2017;8:231-240.
    PubMed     Text format     Abstract available


    Nat Genet

  33. BLAKELY CM, Watkins TBK, Wu W, Gini B, et al
    Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.
    Nat Genet. 2017;49:1693-1704.
    PubMed     Text format     Abstract available


    Oncologist

  34. ODOGWU L, Mathieu L, Goldberg KB, Blumenthal GM, et al
    FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.
    Oncologist. 2017 Dec 14. pii: theoncologist.2017-0425.
    PubMed     Text format     Abstract available


    PLoS One

  35. KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
    Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2017;12:e0189410.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: